These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 334328)

  • 21. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 22. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G
    Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal use of blood components and derivatives.
    Walter WJ; Oberman HA
    Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 25. Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review.
    AGGELER PM
    Transfusion; 1961; 1():71-86. PubMed ID: 13681616
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thromboelastographic findings in transfusion therapy of hemophilic syndromes caused by anti-hemophilic globulin, plasma thromboplastin component and plasma thromboplastic antecedent deficiencies].
    DE NICOLA P; MAZZETTI GM
    Haematologica; 1955; 39(6):361-86. PubMed ID: 13262648
    [No Abstract]   [Full Text] [Related]  

  • 28. New developments in the treatment of pediatric hemophilia and bleeding disorders.
    Branchford BR; Monahan PE; Di Paola J
    Curr Opin Pediatr; 2013 Feb; 25(1):23-30. PubMed ID: 23274430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of inherited coagulation disorders].
    Blombäck M; Nilsson IM
    Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood plasma fractions in the management of coagulation disorders. I. Fibrinogen substitution].
    Richter K
    Z Gesamte Inn Med; 1967 May; 22(10):296-9. PubMed ID: 5586060
    [No Abstract]   [Full Text] [Related]  

  • 31. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of hemorrhagic diatheses].
    Voss D
    Dtsch Med Wochenschr; 1968 May; 93(21):1070-2. PubMed ID: 5658961
    [No Abstract]   [Full Text] [Related]  

  • 33. [Surgical and gynecological indications for transfusion of blood platelets].
    MALAGAMBA G; BECELLI S
    Quad Clin Ostet Ginecol; 1961 Dec; 16():1041-56. PubMed ID: 14468774
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 35. Transfusions in the treatment of hemorrhagic diseases.
    QUICK AJ; GREENWALT TJ; HUSSEY CV
    Transfusion; 1961; 1():99-110. PubMed ID: 13738696
    [No Abstract]   [Full Text] [Related]  

  • 36. Principles of transfusion medicine perioperatively and in intensive care.
    Höcker P
    Acta Anaesthesiol Scand Suppl; 1996; 109():137-8. PubMed ID: 8901983
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of plasma substitutes on coagulation.
    Eichler J; Stephan G
    Bibl Haematol; 1969; 33():452-6. PubMed ID: 5377194
    [No Abstract]   [Full Text] [Related]  

  • 38. Indications for administration of fresh frozen plasma and clotting factor concentrates.
    Muntean W
    Acta Anaesthesiol Scand Suppl; 1996; 109():139-41. PubMed ID: 8901985
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood component therapy in the perinatal period: guidelines and recommendations.
    DePalma L; Luban NL
    Semin Perinatol; 1990 Oct; 14(5):403-15. PubMed ID: 2126893
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significant blood factors for solidity of the thrombus; at the same time a contribution to the problem of unspecific stimulation of hemostasis by transfusions].
    MARX R
    Bibl Haematol; 1957; 6():147-53. PubMed ID: 13510223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.